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Conclusion. Induction of p27KIP1 in this model represents anInduction of p27KIP1 after unilateral ureteral obstruction is inde-
endogenous response to likely limit proliferation that is inde-pendent of angiotensin II.
pendent of angiotensin II. Since there was no close correlationBackground. Unilateral ureteral obstruction (UUO) is char-
between apoptosis and p27KIP1 expression, it may be that theacterized by proliferation of tubular and interstitial cells, and
overall number of p27KIP1 expressing cells sets a general restric-infiltration of the renal parenchyma with macrophages/mono-
tion point for apoptosis rather than defines an individual levelcytes. These alterations lead ultimately to tubulointerstitial
of cell fate.fibrosis and tubular atrophy. Some of these changes are caused
by an activated renin-angiotensin system (RAS). We have pre-
viously demonstrated that angiotensin II induces the expres-
sion of the cell cycle inhibitor p27KIP1 in cultured tubular cells.
Early cellular proliferation has been shown in a varietyThe current study tested the hypothesis that interference with
of renal diseases to be a trigger point in the subsequentthe RAS may modulate renal expression of p27KIP1 after UUO.
Methods. The ureter of the left kidney of Sprague-Dawley development of glomerulosclerosis and tubulointerstitial
rats was ligated. Sham-operated animals served as controls. fibrosis [1, 2]. Proliferation shares a number of regulatory
Rats were randomized in four groups and received one of steps in the early phase with hypertrophic cell growth,the following: no therapy, enalapril, losartan, or triple therapy
and programmed cell death, all processes requiring ac-(hydralazine, reserpine, hydrochlorothiazide). Kidneys were
tive entry into the cell cycle [reviewed in 3]. Althoughremoved and cortical protein lysates were prepared for the
detection of p27KIP1 by Western blotting. Immunohistochemis- much of this information stems from non-renal cells, data
try was performed for p27KIP1, PCNA, ED-1, and -smooth mus- are accumulating on how the growth of glomerular cells
cle actin. Apoptosis was quantified by TUNEL-staining. such as mesangial cells and podocytes is regulated [4].Results. p27KIP1 expression as detected by Western blotting
However, only few in vivo studies of cell cycle regulationreached a maximum 10 days after UUO. Tubular and intersti-
have been performed in models of tubulointerstitial fi-tial cells contributed to this increase in p27KIP1 expression whereas
the number of glomerular p27KIP1 positive cell did not change. brosis [5–7].
p27KIP1-positive cells were macrophages/monocytes (positive Unilateral ureteral obstruction (UUO) is a widely
ED-1 staining) or had the characteristics of myofibroblasts (pos-
used model for obstructive nephropathy resulting in in-itive -smooth muscle actin staining). Tubular and interstitial
jury to the tubular epithelial cells and ultimately tubulo-proliferation [proliferating cell nuclear antigen (PCNA)-posi-
tive staining] and apoptosis [terminal deoxy transferase uridine interstitial fibrosis [8–11]. Accumulating evidence sug-
triphosphate nick end labeling (TUNEL) staining] also was gests that angiotensin II (Ang II) plays an important
increased after UUO. However, individual cells stained either role in the pathophysiology of UUO [8–12]. We and
positive for p27KIP1 or PCNA, but not both. Although enalapril
others have previously shown that Ang II-mediated hy-and losartan reduced the number of macrophages/monocytes
pertrophy depends on the induction of p27KIP1 proteinand attenuated the degree of tubular and interstitial apoptosis,
these drugs did not influence p27KIP1 expression. There was no expression, a cyclin-dependent kinase (CDK) inhibitor
change in the number of p27KIP1-positive cells in the contralat- involved in G1/S phase transit regulation [13–15]. On the
eral kidney undergoing hypertrophy. other hand, an intriguing function of p27KIP1 is its role in
regulatory events of apoptosis [3, 16]. In the absence
of growth factors, increased CDK2 activity in p27KIP1Key words: cell cycle regulation, tubulointerstitial fibrosis, renin-angio-
tensin system, apoptosis, glomerulosclerosis, cellular proliferation. knockout mice leads to markedly enhanced apoptosis
rates [17]. Since tubular hypertrophy (in the contralateralReceived for publication January 12, 2001
kidney) and tubular apoptosis (in the obstructed kidney)and in revised form August 28, 2001
Accepted for publication August 30, 2001 are important features of UUO, the present study was
performed to examine the role of p27KIP1 in this model. 2002 by the International Society of Nephrology
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We also investigated potential effects of therapeutical modification of the Lowry method that is insensitive
to the used concentrations of SDS and DTT. Proteininterference with the renin-angiotensin system (RAS)
concentrations were adjusted to 60 g/sample and 5%on p27KIP1 expression.
glycerol/0.05% bromphenol blue was added. After boil-
ing for ten minutes and centrifugation, supernatants were
METHODS loaded onto a 12% denaturing SDS-polyacrylamide gel.
Animal experimental protocol Prestained low-molecular-weight markers (Amersham,
Braunschweig, Germany) comprising 2,350 to 45,000 Dal-The study was performed with 6-week-old male Sprague-
tons served as molecular weight standards. After comple-Dawley rats (Charles River, Sulzfeld, Germany). Ani-
tion of electrophoresis, proteins were electroblotted ontomals were maintained and treated in compliance with
a nitrocellulose membrane (High-bond-N; Amersham)the institutional guidelines for the care of experimental
in transfer buffer [50 mmol/L Tris (pH 7.0), 380 mmol/Lanimals according to German laws. All animals received
glycine, 20% methanol]. The blots were blocked in 8%a standard laboratory diet (Altromin, Lage, Germany)
non-fat dry milk in PBS with 0.1% Tween 20 for oneand were maintained in 12-hour light/dark cycles. The
hour at room temperature and detection for p27KIP1 wasleft ureter was exposed via a subcostal incision and li-
performed exactly as previously described. A 1:1000 dilu-
gated under anesthesia (ketamine and xylazine). Two tion of a mouse monoclonal anti-p27KIP1 antibody (Trans-
ligations were made between the bladder and the renal duction Laboratories, Lexington, MA, USA) was used as
pelvis followed by dissection of the ureter. In sham oper- primary antibody. This antibody reacts with rat and mouse
ated animals the ureter was mobilized and slightly manip- p27KIP1 [14]. The enhanced chemiluminescence (ECL)
ulated but not ligated. None of the animals developed system was used for the luminescence detection of horse-
signs of wound or systemic infections. radish peroxidase conjugated secondary antibody. Ex-
After 3, 10 and 20 days systolic blood pressures were posed films were scanned with Fluor-ST multi-imager
measured in slightly restrained awake animals using tail- (Bio-Rad Laboratories, Hercules, CA, USA), and data
cuff plethysmography. Blood was drawn and animals were analyzed with the computer program Multi-Analyst
were sacrificed under ether anesthesia. The kidneys were from Bio-Rad. Membranes were stained with Coomassie
immediately removed, decapsulated on ice, washed with Blue after immunodetection to control for equal loading
phosphate-buffered saline (PBS), and then divided for and protein transfer. Western blots were independently
protein extraction and immunohistochemistry. repeated six times.
For therapeutic interventions, additional rats were ran-
Histology and immunohistochemistrydomized into four groups. Six animals in every group
Small specimens of the rat kidney were fixed in methylunderwent unilateral ureteral ligation and five rats were
Carnoy’s solution, embedded in paraffin and cut intosham operated. Antihypertensive treatment was admin-
4 m sections. Tissue sections were deparaffinized withistered with the drinking water ad libitum. Group 1 re-
xylene and rehydrated with graded ethanols. As an anti-ceived no therapy, group 2 was treated with enalapril
gen retrieval technique, sections were microwaved for(100 mg/L), group 3 received losartan (100 mg/L), and
30 minutes and treated with 0.001% trypsin for anothergroup 4 was treated with an antihypertensive triple ther-
15 minutes. The sections were incubated in 5% non-fatapy consisting of hydralazine (80 mg/L), reserpine (5 mg/L)
dry milk for 30 minutes, followed by exposure to a 1:50and hydrochlorothiazide (25 mg/L).
dilution of the p27KIP1 primary antibody diluted in PBS
containing 1% bovine serum albumin (BSA) for 90 min-Plasma renin activity
utes at room temperature. Antibodies against prolifer-Blood for plasma renin activity (PRA) was collected
ating cell nuclear antigen (PCNA; DAKO, Hamburg,during the kidney removal procedure from each animal
Germany), ED-1 (Serotec, Oxford, UK) and -smoothin ethylenediaminetetraacetic acid (EDTA)-containing
muscle actin (Progen, Heidelberg, Germany) were used
tubes on ice. The samples were stored in liquid nitrogen at 1:50, 1:50 and 1:250 dilutions, respectively. After wash-
after plasma separation. PRA was measured as the gen- ing with PBS slides were incubated with a 1:30 dilution of
eration of angiotensin I per milliliter per hour with a RIA appropriate secondary antibodies (DAKO) for 60 min-
using commercially available reagents (Sorin Biomedica, utes. After several washes with PBS, the APAAP com-
Saluggia, Italy). plex was used for visualization using New Fuchsin as
chromogenic agent. For some stainings horseradish per-
Western blotting oxidase-linked secondary antibody was used (DAKO)
Renal cortex was homogenized in lysis buffer [125 with 3,3-diaminobenzidine as chromogenic substrate.
mmol/L Tris-HCl, pH 6.8; 2% sodium dodecyl sulfate The sections were slightly counterstained with Mayer’s
(SDS), 5% glycerol, 0.1 mol/L dithiothreitol (DTT). hematoxylin. Slides incubated with isotype identical
After centrifugation the supernatants were transferred monoclonal antibodies and slides in which the primary
antibody was omitted served as controls.to new tubes. Protein concentration was measured by a
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Table 1. Systolic blood pressures and plasma renin activitiesFor measuring in situ tailing of nuclear fragmenta-
tion using terminal deoxy transferase uridine triphos- Systolic blood pressure Plasma renin activity
Group mm Hg ng Ang I/mL/hphate nick-end labeling (TUNEL) assay, sections were
Sham 10810 2613dewaxed, rehydrated, and incubated with proteinase K
UUO 11915 83c(20 g/mL in 10 mmol/L Tris; pH 7.4) for 15 minutes
Sham triple therapy 1057 4214c
at room temperature with intervening washes in PBS. UUO triple therapy 1028a 319b
Shamenalapril 1005 2414The sections were incubated in a permeating solution
UUOenalapril 967b 283bcomposed of 0.1% Triton X 100 in 0.1% sodium citrate
Sham losartan 1017 5914c,d
buffer for two minutes at 4C. The TUNEL reaction mix- UUO losartan 11118 4716e
ture was prepared by adding 5L terminal deoxynucleo- Abbreviations are: Ang, angiotensin; UUO, unilateral ureteral obstruction.
N  6 per UUO group; N  5 per sham group; N  4 sham and triple therapytidyl transferase (Boehringer Mannheim, Germany) to
group.45 L fluorescein-labeled nucleotide mixture (Boeh- a P  0.05 vs. UUO
b P  0.01 vs. UUOringer Mannheim) per section for 60 minutes at 37C.
c P  0.05 versus shamAfter washes with PBS, sections were treated with a d P  0.05 versus sham  enalapril
e P  0.05 versus UUO  enalaprilhorseradish peroxidase conjugated anti-fluorescein anti-
body (Boehringer Mannheim) for 30 minutes at 37C.
Subsequently, New Fuchsin was used as chromogen. In
control sections, the terminal deoxynucleotidyl trans-
dosage decreased systolic blood pressure, but the valuesferase was omitted. Human tonsils and lymph nodes
failed to reach statistical significance (Table 1).served as positive controls.
Plasma renin activity was significantly reduced afterFor tubular and interstitial cell counts of p27KIP1,
UUO. As expected antihypertensive therapy with triplePCNA, TUNEL and ED-1, cortical fields without any
therapy, enalapril, or losartan led to an increase inglomerulus were chosen. Areas with a moderate degree
plasma renin activities in both control and UUO animalsof tubular dilatation were counted. Tubular and intersti-
(Table 1).tial cells were counted separately in at least five high
power fields from each rat. p27KIP1-positive cells in the Western blotting
glomeruli were given as positive cells/glomerulus.
Western blots of protein lysates isolated from renalA computer aided image analysis system was used to
cortices to study p27KIP1 protein expression were used.assess areas staining positive for -smooth muscle actin.
Figure 1A is a time-course pilot experiment showing anFive fields of each renal cortex containing no arterioles
increase in p27Kip1 protein expression in the obstructedor venules were examined with a magnification of 	40.
kidney as soon as three days after UUO. Staining of theEvery pixel with an optical density over the density of
membrane with Coomassie Blue showed equal loadingcellular structures was counted. Results are expressed
(Fig. 1B). The maximal increase in p27KIP1 protein expres-as mean percentage of the total inspected area of the
sion was observed ten days after obstruction (Fig. 1).measured five fields.
Consequently, a time point of ten days after UUO was
Statistical analysis selected for the intervention experiments and further
immunohistochemical studies. There was no significantAll values are presented as means  standard devia-
increase in p27KIP1 in the contralateral kidney during thetions. To compare two distinct treatment groups (blood
course of the experiment (Fig. 1A). Treatment with ena-pressure, plasma renin activity and density units from
lapril, losartan or triple therapy failed to influence thep27KIP1 Western blotting) the Student t test was applied
increased p27KIP1 protein expression in the obstructedafter checking for normal distribution. The immunohis-
kidney (Fig. 2 and Table 2). Moreover, there was notological counts were evaluated with analysis of variance
influence of any treatment on p27KIP1 expression in the(ANOVA) using the SPSS software package (SPSS, Inc.,
contralateral kidney (Fig. 2). Equal amounts of proteinChicago, IL, USA). A P value of 0.05 was considered
were transferred to the membrane as shown by Coomas-significant.
sie Blue staining after immunodetection (Fig. 2B). A
quantification of densitometric data of Western blots is
RESULTS given in Table 2.
Systolic blood pressures and plasma renin activities
Immunohistochemistry for p27KIP1, PCNA, ED-1, andAfter ten days of UUO, the systolic blood pressure
TUNEL stainingvalues were significantly higher compared with sham-
Immunohistochemistry was performed on consecutiveoperated controls (Table 1). Enalapril and triple therapy,
kidney sections because we found it technically impossi-started directly after surgery, significantly reduced sys-
tolic blood pressure. In contrast, losartan in the used ble to perform double immunostaining for nuclear pro-
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Fig. 1. (A) Western blot for p27KIP1 of protein
lysates from renal cortices at various time-
points after unilateral ureteral obstruction
(UUO). p27KIP1 protein expression was already
increased in the obstructed kidney 3 days after
surgery and this expression peaked at 10 days.
There was no change in the contralateral kid-
ney. This blot is representative for three inde-
pendent experiments with qualitatively simi-
lar changes. (B) Coomassie Blue staining to
prove equal protein loading per lane.
Fig. 2. (A). Example of a Western blot for
p27KIP1 expression studying the potential effect
of interventional treatment at day 10. Although
p27KIP1 significantly increased 10 days after
UUO, triple therapy (triple), enalapril (en-
ala), and losartan (losar) failed to decrease
the stimulated expression. This blot is repre-
sentative for six independent experiments
with qualitatively similar changes. Densito-
metric analysis is given in Table 2. (B) Coo-
massie Blue staining to prove equal protein
loading per lane.
Table 2. Densitometry of p27KIP1 Western blots of interventional either positive for p27KIP1 or PCNA. Immunohistochem-
experiments at day 10
istry for PCNA showed an increase in interstitial and
Group Relative increase in p27KIP1 expression tubular positive cells ten days after UUO compared to
Sham 1.00.0 sham-operated controls (Fig. 3 A, B, and Table 3). Losar-
UUO 10.55.4a tan and triple therapy significantly reduced the number
Contralateral 1.30.8
of PCNA-positive tubular cells, whereas all three treat-Sham triple therapy 1.20.6
UUO triple therapy 14.39.8a ment regimes (triple therapy, enalapril, losartan) attenu-
Contralateral triple therapy 1.10.7 ated the number of interstitial cells that stained positive
Shamenalapril 1.71.6
for PCNA (Fig. 3C and Table 3).UUOenalapril 8.96.0b
Contralateralenalapril 1.51.3 Many interstitial and some tubular cells stained posi-
Sham losartan 1.20.8 tive for p27KIP1 in sham-operated control rats (Fig. 4A and
UUOlosartan 9.96.5a
Table 3). However, the absolute number of interstitialContralateral losartan 1.21.2
as well as tubular cells expressing p27KIP1 significantlyN  6 per UUO group; N  5 per sham group.
a P  0.01 versus sham increased after ten days of UUO (Fig. 4B). Staining of
b P  0.05 versus sham adjacent tissue sections revealed that the majority of the
interstitial p27KIP1-positive cells in the obstructed kidney
also stained positive for ED-1, indicating that these cells
are likely infiltrates composed of macrophages/mono-teins such as p27KIP1 and PCNA on the same section.
cytes (Fig. 5). Neither triple therapy, or enalapril, orPositive nuclear staining for p27KIP1 and PCNA was found
losartan reduced the total number of tubular and intersti-on tubular epithelium and interstitial cells. In consecu-
tive sections it appeared that an individual cell stained tial p27KIP1-positive cells (Fig. 4C and Table 3). There was
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no significant increase in interstitial and tubular p27KIP1-
positive cells in the contralateral kidney at day 10 after
UUO (Table 3). As an additional control, we also quanti-
fied glomerular cells staining positive for p27KIP1. How-
ever, as expected, there was no difference in the number
of p27KIP1-positive cells in sham-operated controls, ob-
structed, or contralateral kidneys (Table 3).
The number of ED-1-positive cells in the tubulointer-
stitium was significantly increased after UUO (Fig. 5
A, B, and Table 3). All antihypertensive therapies sig-
nificantly reduced the number of infiltrating macro-
phages/monocytes (Fig. 5 C–E, and Table 3).
The number of apoptotic tubular and interstitial cells,
as determined with the TUNEL-assay, was markedly
increased after ten days of UUO (Fig. 6 A, B, and
Table 4). Enalapril and losartan treatment significantly
decreased the number of TUNEL-positive tubular and
interstitial cells whereas triple therapy was without sig-
nificant effect (Table 4).
Immunohistochemistry for -smooth muscle actin
Interstitial areas that stained positive for -smooth-
muscle actin were significantly increased in ligated kid-
neys compared with sham-operated controls as quanti-
fied with computer image analysis (Fig. 7 A, B, and Table
4). Therapy with enalapril and losartan, but not triple
therapy, significantly reduced the expression of -smooth-
muscle actin in the obstructed kidney (Fig. 7 C–E, and
Table 4).
DISCUSSION
Development of tubulointerstitial fibrosis in the ob-
structed kidney is the final consequence after unilateral
ureteral obstruction [18, 19]. Initially, proliferation and
apoptosis of tubular cells as well as tubulointerstitial
infiltration of inflammatory cells are well known features
of this model [5, 7]. It is generally assumed that these
growth stimulatory events preceded the development of
tubulointerstitial fibrosis and tubular atrophy.
It is well known that the RAS is activated in UUO
[8, 19–23]. For example, Pimentel et al demonstrated
an up-regulation of renin mRNA, and protein, angioten-
sin-converting enzyme (ACE) activity, and Ang II levels
in the obstructed kidney whereas Ang II subtype 1 (AT1)
receptor transcripts were down-regulated [11]. Renin
mRNA and ACE activity also were down-regulated in the
contralateral kidney [11]. PRA was significantly down-
Fig. 3. Immunohistochemical staining for proliferating cell nuclear an- regulated ten days after UUO in our study, whereas
tigen (PCNA) as a proliferation marker. (A) Sham-operated control treatment with an ACE inhibitor attenuated this phe-showed only very few PCNA-positive tubular and interstitial cells. (B)
nomenon. The AT1 receptor blocker led to a furtherHowever, at day 10 after UUO the number of PCNA-positive tubular
and interstitial cells significantly increased in the obstructed kidney. significant increase in PRA. Controversial observations
(C ) Losartan treatment reduced the number of PCNA-positive tubular regarding the PRA after UUO have been published. El-and interstitial cells. Original magnification 	200.
Dahr et al found that PRA increased after one week
and to a lesser extent after five weeks of UUO [21]. This
is in contradiction to data from Pimentel and co-workers,
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Table 3. Quantification of p27KIP1, PCNA, and ED-1 stainings 10 days after UUO
Sham UUO Contra Sham UUO Contra Sham UUO Contra
Sham UUO Contra triple therapy enalapril losartan
p27KIP1 tubular
cells/	field 532145 61995a 492126 426110 609142a 56584 50576 67554a 477115 48278 67386a 52371
p27KIP1 interstitial
cells/	field 20959 418108a 20239 14738 324107a 24234 24397 39578a 22246 18554 42184a 21850
p27KIP1 positive
cells/	glomerulus 3410 3512 3510 3210 3310 3610 378 338 339 3611 359 389
PCNA tubular
cells/	field 73 6521a 178 74 3719b 138 94 5919a 145 105 5018b 148
PCNA interstitial
cells/	field 94 6721a 199 124 5018b 188 115 5816b 167 137 5218b 187
ED-1 interstitial
cells/	field 73 4514a 52 64 248b 42 62 308b 62 62 2610b 61
N  6 per UUO group; N  5 per sham group.
a P  0.05 versus sham-opearted controls
b P  0.05 versus untreated UUO
who found PRA to be elevated only for 12 hours and kidneys showing p27KIP1 expression in all three resident
glomerular cell populations.normalized as early as 24 hours after UUO [24]. Indeed,
Tubular and interstitial PCNA-positive cells signifi-another contribution of El-Dahr and colleagues reported
cantly increased after ten days. However, it appeareda decrease of PRA after four weeks [20]. Since PRA is
that individual cells were found to be either positive forsuppressed by local Ang II concentrations, we believe
PCNA or p27KIP1. Since we were not able to performthat decreased PRA in our study was due to high local
double-staining for PCNA and p27KIP1, it cannot be ruledAng II levels. It is well known that ACE-inhibitors and
out that there may be nuclei expressing both PCNAAT1-receptor antagonists interfere with this feedback
and p27KIP1. This increase in PCNA-positive cells is inmechanism that is mediated through AT1-receptors. In
agreement with previous studies from several investiga-agreement with our data, Ishidoya et al showed an in-
tors and likely reflects the proliferation of interstitialcrease in PRA after application of ACE inhibitors and
and tubular cells [5–7, 17, 18]. Finally, TUNEL-positiveAT1 receptor antagonists in UUO-treated rats [8].
tubular and interstitial cells were both significantly in-Several groups have demonstrated that an activation
creased in the obstructed kidney.of the RAS plays a critical role in mediating different
In accordance with previous reports ACE inhibitorpathophysiological phenomena contributing to at least
treatment reduced the interstitial infiltrate of ED-1–50% of the interstitial fibrosis found in obstructive ne-
positive cells [22]. Moreover, the AT1 receptor antago-phropathy [9]. Since we have previously described that
nist losartan also was effective in reducing the numberexposure of proximal tubular cells to Ang II as well as
of macrophages/monocytes. This finding is somewhat ininfusion of this peptide into native rats stimulate tubular
contradiction to recent data showing no effect of AT1p27KIP1 expression [13, 25], we were interested in changes
receptor blockade on ED-1–positive infiltrates in the
of this CDK inhibitor in the rat model of UUO and the
obstructed kidney [22], but may be due to different phar-
potential relationships of p27KIP1 expression, apoptosis, macological kinetics of the AT1 receptor antagonists usedproliferation, and the ultimate development of intersti- as well as varying doses. We previously found that the
tial fibrosis. particular dose of losartan significantly reduced glomeru-
p27KIP1 protein expression, as detected by Western blot- lar infiltration of macrophages/monocytes in a model of
ting of cortical lysates, was up-regulated approximately mesangioproliferative nephritis [26].
tenfold in the time course following UUO with a peak Changes in cell number (proliferation, apoptosis) and
ten days after ligation. Immunohistochemical staining cell size (hypertrophy) are regulated principally by cell
revealed that some tubules and occasionally tubulointer- cycle proteins [3, 27]. Transition between different phases
stitial cells stained positive for p27KIP1 under control con- of the cell cycle is regulated positively by the kinase
ditions in sham-operated animals. However, UUO signif- activity of an enzyme that is composed of two subunits:
icantly increased tubular and interstitial p27KIP1-positive cyclins and their partner, the CDKs. On the other hand,
cells. p27KIP1-positive interstitial cells mainly consisted of these complexes are regulated negatively by small pro-
resident myofibroblasts (positive for -smooth muscle teins named CDK inhibitors. Cyclin E/CDK2 complexes
actin) and immigrated macrophages/monocytes (ED-1 of the G1 phase are inhibited by p27KIP1. In contrast to
positive). Compared with untreated controls, glomerular other CDK inhibitors such as p21, p27KIP1 expression
is mainly post-transcriptionally regulated by changes instaining was not different in ligated and contralateral
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protein translation and degradation, and is not regulated
by p53 [3, 28]. Previous studies clearly have demon-
strated that overexpression of p27KIP1 leads to inhibition
of proliferation and eventual induction of hypertrophy
[29]. On the other hand, mesangial cells obtained from
p27KIP1 
/
 mice showed an increase in proliferation if
incubated in the presence of appropriate growth factors
[16]. Interestingly, Hiromura et al demonstrated in ele-
gant studies that apoptosis is enhanced in p27KIP1 
/

mesangial cells under conditions of growth factor depri-
vation [16]. This increased apoptosis was associated with
an unconstrained increase in cyclin A/CDK2 activity,
but not cyclin E/CDK2 activity [16]. Tubular epithelial
cell proliferation and apoptosis was significantly in-
creased in p27KIP1
/
mice following UUO compared to
animals with intact p27KIP1 [17]. Truong and co-workers
reported that during the early phase after UUO mostly
tubular cells are found to be PCNA-positive with a peak
around day 6 [7]. At later points, PCNA-positive staining
declined in tubular cells, while interstitial cells became
increasingly positive up to day 90 after UUO [7]. It is
therefore possible that the progressive increase in p27KIP1
expression up to day 10 limits the further proliferative
response of tubular cells after day 5. Thus, we believe
that the increase in p27KIP1 expression in tubular and
interstitial cells may be a compensatory mechanism to
limit overshooting proliferation that would interfere with
potential tubular repair processes.
Various antihypertensive therapies including regimens
with an ACE inhibitor or an AT1 receptor antagonist
failed to decrease tubular and interstitial p27KIP1 expres-
sion. However, losartan reduced the absolute numbers
of PCNA-positive interstitial and tubular cells, sug-
gesting that proliferation may be mediated through AT1-
receptors. A somewhat surprising finding was the obser-
vation that triple therapy significantly reduced tubular
and interstitial PCNA staining. However, a recent study
in which a continuous, subcutaneous Ang II infusion
induced an increase in the number of PCNA-positive
interstitial and tubular cells revealed that co-application
of hydralazine partially reduced this proliferation [30].
Hydralazine also inhibits activation of membrane-bound
NADH oxidase [31]. This enzyme plays a pivotal role
in Ang II-induced reactive oxygen radical formation and,
through subsequent activation of mitogen-activated pro-
tein kinases, may influence cell growth [14, 32]. Thus,
the vasodilator hydralazine as part of the triple therapy
Fig. 4. Immunohistochemistry for p27KIP1. (A) Few tubular and many may have some direct or indirect antiproliferative prop-
interstitial cells stained positive for p27KIP1 in sham-operated controls. erties in situations with high Ang II.
(B) However, the absolute number of tubular and interstitial p27KIP1-
On the other hand, ACE inhibitor treatment failed topositive cells increased in the obstructed kidney. (C ) Enalapril, as an
example for interventional treatment, failed to influence the number attenuate the stimulated proliferation of interstitial and
of p27KIP1-positive cells. Original magnification 	200. tubular cells. The effect of enalapril on blood pressure,
PRA, and on ED1-positive as well as TUNEL-positive
cells clearly demonstrates that the rats received the ACE
inhibitor in sufficient amounts. Morrissey et al showed
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Fig. 5. Macrophages/monocytes identified by their staining for the ED-1
antigen. (A) Sham-operated controls. (B) Strong increase in ED-1-
positive cells in the tubulointerstitium in the obstructed kidney at day
10. Antihypertensive treatment with triple therapy (C ), enalapril (D),
and losartan (E) all reduced the increased number of macrophages/
monocytes in the ligated kidney. Original magnification 	200.
suppressed cellular proliferation five days after UUO lar regeneration. An alternative explanation as sup-
ported by our data may be that enalapril reduced apopto-when ACE inhibitor therapy was already started 24
hours before ligation [6]. Since proliferation reaches its sis to a greater extent than proliferation. Therefore, the
overall effect could be no change in the total number ofpeak five days after ligation [7], the failure of enalapril
to reduce tubular proliferation in our studies at day 10 PCNA-positive cells. Moreover, our Western blot exper-
iments demonstrate a maximal expression of p27KIP1 atafter UUO may be explained by the time-course of tubu-
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Fig. 6. TUNEL-staining for apoptotic cells. (A) Only very few tubular
and interstitial cells were TUNEL-positive in sham-operated controls.
(B) However, the number of apoptotic cells markedly increased after
10 days of UUO. Enalapril (C ) as well as losartan (D) treatment
significantly decreased the number of TUNEL-positive cells in the ob-
structed kidney whereas triple therapy (E) was without significant effect.
Original magnification 	200.
day 10. In the first investigation studying cell cycle regula- the presence of other growth factors, Ang II can stimu-
late proliferation or can alternatively induce hypertro-tion in UUO, Morrissey and coworkers found a maximal
induction of p21CIP1/WAF1, another CDK-inhibitor, eight phy [2]. These responses are necessarily exclusive be-
cause Ang II-mediated proliferation requires completiondays after UUO [6]. Thus, the up-regulation of this CDK-
inhibitor may contribute to limiting proliferation at this of the cell cycle whereas hypertrophy is characterized by
G1-phase arrest without completion of the cycle. Severaltime point. In addition, depending on the cell type and
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Table 4. Quantification of TUNEL, and -smooth muscle actin stainings 10 days after UUO
Sham UUO Contra Sham UUO Contra Sham UUO Contra
Sham UUO Contra triple therapy enalapril losartan
TUNEL tubular
cells/	field 0.40.7 5.04.4a 0.30.1 0.080.2 3.93.2a 0.10.3 0.040.2 2.21.9b 0.030.1 0.20.6 2.42.2b 0.20.6
TUNEL interstitial
cells/	field 0.20.5 3.23.2a 0.20.4 0.10.3 2.72.7a 0.20.4 0.050.2 1.11.2b 0.070.2 0.080.3 1.41.5b 0.20.5
-smooth muscle
actin interstitial % 1.20.7 4.61.9a NM 0.80.3 4.82.0a NM 1.00.5 4.02.1b NM 0.50.3 4.12.0b NM
N  6 per UUO group; N  5 per sham group; NM, not measured.
a P  0.05 versus sham-operated controls
b P  0.05 versus untreated UUO
groups have independently demonstrated that Ang II the observation that Ang II may also transmit death
signals through AT1 receptors. Attenuation of apoptosisinduces hypertrophy of cultured tubular cells from vari-
ous species and also may play a role in glomerular en- in tubular and interstitial cells was not associated with
a significant change in p27KIP1 expression, indicating thatlargement during diabetic nephropathy [32–34]. We have
previously discovered that p27KIP1 is pivotal for the induc- a change in this CDK inhibitor is not a necessary prereq-
uisite for apoptosis. However, only less than 10% of alltion of Ang II-mediated hypertrophy requiring G0-phase
arrest [13, 14, 32]. Moreover, ACE-inhibitor treatment p27KIP1-positive cells eventually undergo apoptosis. Thus,
it is possible that p27KIP1 expression generally limits apo-also reduces hypertrophy and p27KIP1 expression in dia-
betic glomerulopathy [35]. Since tubular cells undergo ptosis and that many more cells would engage in pro-
grammed cells death in the obstructed kidney if p27KIP1proliferation after UUO, it is unlikely that Ang II plays
a role in this process. The increase in p27KIP1 may repre- expression would not concomitantly increase. Then the
actual induction of apoptosis in individual cells is trig-sent an intrinsic response to limit tubular proliferation as
also indicated by the elegant studies of Ophascharoensuk gered, at least to some extent, by Ang II.
The contralateral kidney undergoes compensatory hy-and collaborators performing UUO in p27Kip1 
/
 mice
[17]. Hence, p27Kip1 regulation in the obstructed kidney pertrophy after unilateral obstruction. We previously
found that the Ang II-induced hypertrophy of culturedis not part of an Ang II-mediated hypertrophic response
explaining the failure of enalapril and losartan to attenu- tubules depends on p27KIP1-mediated G1 phase arrest [13,
14, 32]. However, there was no increase in p27KIP1-posi-ate p27KIP1 expression. However, other CDK inhibitors
may be differentially regulated and enalapril significantly tive tubular cells in the contralateral kidney at day 10 after
UUO. Furthermore, interference with the RAS failed toreduced the increased expression of p21CIP1/WAF1 in the
obstructed kidney [6]. modulate p27KIP1 expression in the contralateral kidney.
These data indicate that the compensatory growth re-In accordance with previous studies, we found a sig-
nificant increase in apoptosis of tubular and interstitial sponses of the contralateral kidney are independent of
Ang II-mediated p27KIP1 expression in this model. Thesecells at day 10 after UUO [7]. However, there was some
variation in TUNEL-positive cells between individual data are in good agreement with a recent report by Fern
and co-workers demonstrating that compensatory hyper-animals. This variation was found also by Choi et al, and
other parameters for detecting apoptosis may be better trophy of the contralateral kidney occurs in UUO in-
duced in angiotensinogen knockout mice [9].than TUNEL staining [36]. Choi et al described that
tubular apoptosis appeared at day 4 after ureter ligation In summary, our data demonstrate that p27KIP1 expres-
sion is increased in tubular and interstitial cells in theand peaked at day 15 [36]. In the obstructed kidney,
expression of several apoptosis-related molecules such obstructed kidney. Interstitial cells staining positive for
p27KIP1 were either macrophages/monocytes or myofi-as Fas, Fas ligand, and caspase-8 was increased [36]. In
the present study, apoptosis of tubular and interstitial broblasts. Although treatment with an ACE inhibitor or
losartan reduced apoptosis of tubular and interstitialcells, as detected with TUNEL-staining, was reduced by
enalapril and losartan, but not by triple therapy, indicat- cells and attenuated the number of ED-1 and -smooth
muscle positive cells in the tubulointerstitium, there wasing that part of this programmed cell death is Ang II-
dependent. Although AT2-receptors have been impli- no significant change in the number of p27KIP1-positive
cells. No change in the p27KIP1 expression was detectedcated in transducing proapoptotic effects of Ang II [37],
there is clear evidence that the AT1 receptor subtype in the contralateral kidney undergoing hypertrophy. Our
data suggest that induction of p27KIP1 in this model ismay be involved in this process [38]. Our findings that
losartan treatment reduces the number of tubular and complex and probably represents an intrinsic response
of tubular and interstitial cells limiting proliferation afterinterstitial TUNEL-positive cells is in agreement with
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Fig. 7. Immunohistochemical staining for -smooth muscle actin. (A)
Sham-operated controls. (B) Increase in -smooth muscle actin staining
after UUO. Enalapril (C ) as well as losartan (D) treatment significantly
reduced -smooth muscle positive areas in the obstructed kidney,
whereas triple therapy (E) was without significant effect. Original mag-
nification 	200.
and published in abstract form (J Am Soc Nephrol 10:491A, 1999).injury. This induction of cell cycle arrest is not Ang II-
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